Effects of phospholipase A2 inhibitors on diethyl maleate-induced lipid peroxidation and cellular injury in isolated rat hepatocytes.
Isolated hepatocytes provide a suitable system for investigation of various aspects of the mechanism of a toxic response. The mechanism by which most chemicals induce hepatotoxicity is still not known. Evidence that phospholipases may play a role in cellular injury has been reported. In the present study the effects of reported inhibitors of phospholipase A2 (quinacrine, chlorpromazine, dexamethasone, and dibutyryl cyclic AMP) on diethyl maleate (DEM)-induced lipid peroxidation, reduced glutathione (GSH) depletion, and cellular injury were examined in isolated hepatocyte suspensions. Hepatocytes were incubated for 7 h under control conditions or with (1) DEM (4 mM), (2) one of the inhibitors (quinacrine, 10, 50, or 150 microM; chlorpromazine, 50 microM; dexamethasone, 0.1, 0.5, 1, or 2.5 mM; dibutyryl cyclic AMP, 0.1, 0.5, 1, or 2.5 mM) or aspirin (500 microM), or (3) a combination of DEM and one of the inhibitors or aspirin to determine their effect on DEM toxicity. Samples were withdrawn at hourly intervals for estimation of cellular injury (loss of intracellular K+ and lactate dehydrogenase and trypan blue exclusion index), lipid peroxidation (thiobarbituric acid reactants assay), and GSH concentration. Quinacrine and chlorpromazine inhibited DEM-induced lipid peroxidation but not cellular injury or GSH loss. This suggests that phospholipase A2 may be involved in DEM-induced lipid peroxidation but not cell damage. However, dexamethasone and dibutyryl cyclic AMP enhanced both lipid peroxidation and loss of cell viability due to DEM, suggesting novel aspects of the biochemical mechanisms of chemically induced cytotoxicity.
D000818:Animals; D001241:Aspirin / Q000494:pharmacology; D003994:Bucladesine / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D003907:Dexamethasone / Q000494:pharmacology; D005978:Glutathione / Q000032:analysis; D066298:In Vitro Techniques; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D008054:Lipid Peroxides / Q000378:metabolism*; D008099:Liver / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D008298:Maleates / Q000633:toxicity*; D010740:Phospholipases / Q000037:antagonists & inhibitors*; D010741:Phospholipases A / Q000037:antagonists & inhibitors*; D054467:Phospholipases A2; D011796:Quinacrine / Q000633:toxicity; D051381:Rats
D008054:Lipid Peroxides; D008298:Maleates; D003994:Bucladesine; D003907:Dexamethasone; D007770:L-Lactate Dehydrogenase; D010740:Phospholipases; D010741:Phospholipases A; D054467:Phospholipases A2; C014476:diethyl maleate; D005978:Glutathione; D011796:Quinacrine; D001241:Aspirin; D002746:Chlorpromazine